Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Leukemia, Hairy Cell | 114 | 2011 | 186 | 6.540 |
Why?
|
Interferon Type I | 35 | 1994 | 186 | 1.550 |
Why?
|
Lung Neoplasms | 77 | 2001 | 2362 | 1.480 |
Why?
|
Interferon-alpha | 21 | 2008 | 214 | 1.330 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 38 | 2018 | 2499 | 0.990 |
Why?
|
Pentostatin | 17 | 2011 | 30 | 0.970 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 27 | 2001 | 1123 | 0.970 |
Why?
|
Chromosome Aberrations | 40 | 1989 | 386 | 0.750 |
Why?
|
Splenectomy | 35 | 1998 | 82 | 0.720 |
Why?
|
Antineoplastic Agents | 35 | 2015 | 2323 | 0.660 |
Why?
|
Hodgkin Disease | 22 | 1998 | 181 | 0.600 |
Why?
|
Vinblastine | 15 | 1998 | 100 | 0.540 |
Why?
|
Leukemia | 23 | 1988 | 322 | 0.520 |
Why?
|
Cladribine | 6 | 2011 | 35 | 0.510 |
Why?
|
Humans | 317 | 2018 | 89500 | 0.470 |
Why?
|
Carcinoma, Small Cell | 20 | 1987 | 133 | 0.470 |
Why?
|
Cisplatin | 12 | 1998 | 597 | 0.470 |
Why?
|
Bone Marrow | 43 | 1998 | 443 | 0.460 |
Why?
|
Combined Modality Therapy | 34 | 1998 | 1705 | 0.440 |
Why?
|
Neoplasm Staging | 44 | 1998 | 1997 | 0.440 |
Why?
|
Recombinant Proteins | 28 | 2000 | 1008 | 0.440 |
Why?
|
Middle Aged | 162 | 2001 | 25971 | 0.440 |
Why?
|
Lymphoma | 18 | 1989 | 266 | 0.430 |
Why?
|
Immunologic Factors | 4 | 2008 | 171 | 0.400 |
Why?
|
Paclitaxel | 9 | 1998 | 474 | 0.400 |
Why?
|
Aged | 121 | 2001 | 19124 | 0.390 |
Why?
|
Adult | 144 | 2018 | 26659 | 0.380 |
Why?
|
Carcinoma, Bronchogenic | 18 | 1986 | 30 | 0.380 |
Why?
|
Male | 181 | 2001 | 42438 | 0.370 |
Why?
|
Spleen | 19 | 1995 | 433 | 0.360 |
Why?
|
Leukemia, Myeloid | 12 | 2000 | 249 | 0.340 |
Why?
|
Antineoplastic Agents, Phytogenic | 6 | 1998 | 274 | 0.340 |
Why?
|
Leukemia, Lymphoid | 22 | 1986 | 72 | 0.340 |
Why?
|
Survival Analysis | 6 | 2008 | 1496 | 0.330 |
Why?
|
Female | 162 | 2018 | 46328 | 0.330 |
Why?
|
Remission Induction | 19 | 1996 | 740 | 0.320 |
Why?
|
Lymphocytes | 24 | 1989 | 468 | 0.310 |
Why?
|
Interferons | 11 | 1992 | 127 | 0.300 |
Why?
|
Gallium Radioisotopes | 9 | 1989 | 31 | 0.280 |
Why?
|
Ifosfamide | 11 | 1998 | 48 | 0.280 |
Why?
|
Granulocyte Colony-Stimulating Factor | 11 | 2001 | 166 | 0.260 |
Why?
|
Chlorambucil | 10 | 1988 | 23 | 0.260 |
Why?
|
Leukemia, Myeloid, Acute | 18 | 1993 | 797 | 0.250 |
Why?
|
Karyotyping | 33 | 2000 | 253 | 0.250 |
Why?
|
Enzyme Inhibitors | 1 | 2008 | 642 | 0.250 |
Why?
|
Adenocarcinoma | 23 | 1995 | 1185 | 0.240 |
Why?
|
Drug Administration Schedule | 16 | 1998 | 865 | 0.230 |
Why?
|
Coformycin | 6 | 1989 | 9 | 0.230 |
Why?
|
Leucovorin | 12 | 1995 | 223 | 0.230 |
Why?
|
Lymphoma, Non-Hodgkin | 8 | 1991 | 261 | 0.230 |
Why?
|
Monocytes | 11 | 1988 | 219 | 0.230 |
Why?
|
Interferon-gamma | 5 | 1989 | 448 | 0.220 |
Why?
|
Thoracic Neoplasms | 3 | 1998 | 66 | 0.220 |
Why?
|
Microscopy, Electron | 22 | 1992 | 511 | 0.220 |
Why?
|
Cyclophosphamide | 21 | 1992 | 301 | 0.210 |
Why?
|
Doxorubicin | 14 | 1992 | 294 | 0.200 |
Why?
|
Receptors, Antigen, B-Cell | 12 | 1989 | 116 | 0.200 |
Why?
|
Neoplasms, Multiple Primary | 6 | 1986 | 103 | 0.200 |
Why?
|
Prognosis | 39 | 1993 | 3777 | 0.190 |
Why?
|
Fluorouracil | 6 | 1995 | 550 | 0.190 |
Why?
|
Camptothecin | 2 | 2001 | 195 | 0.190 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 13 | 1989 | 152 | 0.190 |
Why?
|
Chromosomes, Human, 13-15 | 13 | 1984 | 32 | 0.190 |
Why?
|
Receptors, Interleukin-2 | 2 | 1990 | 67 | 0.180 |
Why?
|
Chromosomes | 8 | 1976 | 98 | 0.180 |
Why?
|
Taxoids | 2 | 1998 | 124 | 0.180 |
Why?
|
HLA Antigens | 3 | 1992 | 227 | 0.170 |
Why?
|
Methotrexate | 17 | 1992 | 242 | 0.170 |
Why?
|
Chromosomes, Human, Pair 5 | 2 | 2000 | 109 | 0.170 |
Why?
|
Tetradecanoylphorbol Acetate | 5 | 1988 | 137 | 0.170 |
Why?
|
Follow-Up Studies | 23 | 2000 | 3658 | 0.160 |
Why?
|
Microscopy, Electron, Scanning | 15 | 1988 | 141 | 0.160 |
Why?
|
Carcinoma, Squamous Cell | 18 | 1995 | 1097 | 0.160 |
Why?
|
Ribonucleosides | 2 | 1989 | 25 | 0.160 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 1 | 2018 | 21 | 0.150 |
Why?
|
Ipilimumab | 1 | 2018 | 60 | 0.150 |
Why?
|
Phagocytosis | 5 | 1982 | 86 | 0.150 |
Why?
|
Lymphatic Diseases | 7 | 1977 | 36 | 0.150 |
Why?
|
Chromosomes, Human, 16-18 | 10 | 1984 | 26 | 0.150 |
Why?
|
Drug Therapy, Combination | 26 | 1990 | 782 | 0.150 |
Why?
|
Bone Marrow Transplantation | 3 | 1989 | 283 | 0.140 |
Why?
|
Procarbazine | 12 | 1992 | 40 | 0.140 |
Why?
|
Antigens, Neoplasm | 2 | 1990 | 334 | 0.140 |
Why?
|
Survival Rate | 14 | 2001 | 1886 | 0.140 |
Why?
|
Osteolysis | 2 | 1988 | 14 | 0.140 |
Why?
|
Leukocyte Count | 11 | 1989 | 223 | 0.140 |
Why?
|
Leukemia, Monocytic, Acute | 5 | 1987 | 14 | 0.140 |
Why?
|
Neoplasms | 8 | 2015 | 3052 | 0.130 |
Why?
|
Alkaline Phosphatase | 5 | 1988 | 132 | 0.130 |
Why?
|
Antineoplastic Agents, Immunological | 1 | 2018 | 199 | 0.130 |
Why?
|
Radiation-Sensitizing Agents | 1 | 1996 | 97 | 0.130 |
Why?
|
Prescription Fees | 1 | 2015 | 10 | 0.130 |
Why?
|
Melanoma | 2 | 2018 | 467 | 0.130 |
Why?
|
Chromatin | 6 | 1976 | 401 | 0.130 |
Why?
|
Patient Advocacy | 1 | 2015 | 53 | 0.120 |
Why?
|
Brain Neoplasms | 6 | 1989 | 785 | 0.120 |
Why?
|
Drug Costs | 1 | 2015 | 63 | 0.120 |
Why?
|
Acute Disease | 13 | 2000 | 841 | 0.120 |
Why?
|
Neutropenia | 7 | 1998 | 214 | 0.120 |
Why?
|
Myelodysplastic Syndromes | 2 | 1996 | 359 | 0.120 |
Why?
|
Lymph Nodes | 11 | 1989 | 550 | 0.110 |
Why?
|
Chromosomes, Human, 6-12 and X | 10 | 1986 | 23 | 0.110 |
Why?
|
Antigens, Differentiation | 2 | 1991 | 141 | 0.110 |
Why?
|
Aged, 80 and over | 14 | 2000 | 6761 | 0.110 |
Why?
|
Clinical Trials as Topic | 13 | 1998 | 1131 | 0.110 |
Why?
|
Neoplasm Recurrence, Local | 8 | 1988 | 1353 | 0.110 |
Why?
|
Patient Participation | 1 | 2015 | 225 | 0.110 |
Why?
|
Drug Evaluation | 9 | 1991 | 137 | 0.110 |
Why?
|
Phorbols | 4 | 1985 | 9 | 0.110 |
Why?
|
Chromosome Deletion | 6 | 2000 | 226 | 0.110 |
Why?
|
Whole-Body Counting | 2 | 1989 | 7 | 0.100 |
Why?
|
Radionuclide Imaging | 11 | 1989 | 222 | 0.100 |
Why?
|
Neoplasm Metastasis | 15 | 1989 | 1064 | 0.100 |
Why?
|
Vincristine | 12 | 1990 | 111 | 0.100 |
Why?
|
Mycobacterium Infections | 4 | 1986 | 15 | 0.100 |
Why?
|
Biopsy | 12 | 1988 | 1183 | 0.100 |
Why?
|
Granulocytes | 4 | 1986 | 38 | 0.100 |
Why?
|
Antigens, Surface | 3 | 1990 | 102 | 0.100 |
Why?
|
Laparotomy | 6 | 1998 | 68 | 0.100 |
Why?
|
Blood Cell Count | 9 | 1987 | 79 | 0.100 |
Why?
|
Antigens, Differentiation, B-Lymphocyte | 1 | 1991 | 20 | 0.100 |
Why?
|
Interleukin-2 | 2 | 1990 | 241 | 0.100 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2011 | 76 | 0.090 |
Why?
|
Treatment Outcome | 8 | 2011 | 8200 | 0.090 |
Why?
|
Trisomy | 3 | 1989 | 54 | 0.090 |
Why?
|
B-Lymphocytes | 11 | 1988 | 740 | 0.090 |
Why?
|
Bacterial Infections | 2 | 1984 | 184 | 0.090 |
Why?
|
Rituximab | 1 | 2011 | 117 | 0.090 |
Why?
|
Translocation, Genetic | 13 | 1986 | 265 | 0.090 |
Why?
|
Pancytopenia | 6 | 1993 | 23 | 0.090 |
Why?
|
Bone Marrow Cells | 9 | 1983 | 262 | 0.090 |
Why?
|
Neoplasm Proteins | 6 | 1987 | 538 | 0.090 |
Why?
|
Mycobacterium Infections, Nontuberculous | 3 | 1986 | 27 | 0.090 |
Why?
|
Leukapheresis | 4 | 1990 | 20 | 0.090 |
Why?
|
Interleukin-4 | 1 | 1990 | 129 | 0.090 |
Why?
|
Hydroxyurea | 4 | 1995 | 239 | 0.090 |
Why?
|
Carboplatin | 3 | 1998 | 310 | 0.080 |
Why?
|
Splenomegaly | 6 | 1995 | 28 | 0.080 |
Why?
|
Chromosome Disorders | 12 | 1988 | 113 | 0.080 |
Why?
|
Mitosis | 7 | 1981 | 152 | 0.080 |
Why?
|
Antigens, CD | 1 | 1991 | 466 | 0.080 |
Why?
|
Carcinoma | 4 | 1986 | 438 | 0.080 |
Why?
|
Pneumonectomy | 4 | 1995 | 209 | 0.080 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 1989 | 106 | 0.080 |
Why?
|
Platelet Count | 6 | 1989 | 93 | 0.080 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 1988 | 97 | 0.080 |
Why?
|
Phospholipids | 3 | 1984 | 112 | 0.080 |
Why?
|
Immunoenzyme Techniques | 1 | 1988 | 303 | 0.080 |
Why?
|
Receptors, Drug | 2 | 1984 | 54 | 0.080 |
Why?
|
Time Factors | 19 | 2001 | 5330 | 0.070 |
Why?
|
Antineoplastic Agents, Alkylating | 3 | 1998 | 135 | 0.070 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 1988 | 48 | 0.070 |
Why?
|
Sex | 1 | 1987 | 6 | 0.070 |
Why?
|
Leukocytes | 5 | 1984 | 208 | 0.070 |
Why?
|
Protein Kinase C | 2 | 1984 | 267 | 0.070 |
Why?
|
Mucormycosis | 1 | 1986 | 15 | 0.070 |
Why?
|
Organoplatinum Compounds | 1 | 1987 | 95 | 0.070 |
Why?
|
Thrombocytopenia | 4 | 1995 | 187 | 0.070 |
Why?
|
Bone and Bones | 3 | 1989 | 271 | 0.070 |
Why?
|
Caenorhabditis elegans Proteins | 2 | 1984 | 113 | 0.070 |
Why?
|
Recurrence | 8 | 1995 | 1143 | 0.070 |
Why?
|
Testis | 1 | 1987 | 152 | 0.070 |
Why?
|
Bone Neoplasms | 3 | 1986 | 320 | 0.070 |
Why?
|
Chromosomes, Human, 21-22 and Y | 8 | 1982 | 14 | 0.070 |
Why?
|
Staining and Labeling | 9 | 1984 | 168 | 0.060 |
Why?
|
Cytoplasmic Granules | 4 | 1980 | 96 | 0.060 |
Why?
|
Occupational Diseases | 2 | 1982 | 55 | 0.060 |
Why?
|
Sex Chromosomes | 4 | 1980 | 57 | 0.060 |
Why?
|
Prednisone | 6 | 1990 | 253 | 0.060 |
Why?
|
Neoplasms, Second Primary | 2 | 2000 | 260 | 0.060 |
Why?
|
T-Lymphocytes | 6 | 1990 | 1221 | 0.060 |
Why?
|
Lymphoproliferative Disorders | 2 | 1988 | 111 | 0.060 |
Why?
|
Retrospective Studies | 14 | 1992 | 9097 | 0.060 |
Why?
|
Neutrophils | 5 | 1987 | 309 | 0.060 |
Why?
|
Platelet Aggregation | 3 | 1979 | 44 | 0.060 |
Why?
|
Cell Division | 4 | 1990 | 692 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 8 | 1998 | 1928 | 0.060 |
Why?
|
Cohort Studies | 4 | 1995 | 2876 | 0.060 |
Why?
|
Cells, Cultured | 10 | 1989 | 2884 | 0.060 |
Why?
|
Bleomycin | 2 | 1990 | 102 | 0.060 |
Why?
|
Cytarabine | 7 | 1990 | 219 | 0.060 |
Why?
|
Sinusitis | 1 | 1986 | 215 | 0.060 |
Why?
|
Hematopoietic Stem Cells | 2 | 1992 | 303 | 0.060 |
Why?
|
Bone Resorption | 1 | 1984 | 42 | 0.060 |
Why?
|
Cholesterol | 3 | 1984 | 360 | 0.060 |
Why?
|
Abdomen | 3 | 1990 | 123 | 0.060 |
Why?
|
Cell Membrane | 8 | 1987 | 675 | 0.060 |
Why?
|
Altretamine | 2 | 1986 | 4 | 0.060 |
Why?
|
Leukopenia | 3 | 1994 | 66 | 0.060 |
Why?
|
Lomustine | 2 | 1986 | 26 | 0.060 |
Why?
|
DNA, Recombinant | 3 | 1990 | 67 | 0.060 |
Why?
|
Hypercalcemia | 1 | 1984 | 63 | 0.060 |
Why?
|
Bronchoscopy | 3 | 1985 | 162 | 0.060 |
Why?
|
Pleural Effusion | 3 | 1986 | 47 | 0.060 |
Why?
|
Heart Transplantation | 1 | 1989 | 717 | 0.050 |
Why?
|
Acid Phosphatase | 5 | 1988 | 34 | 0.050 |
Why?
|
Hemoglobins | 3 | 1995 | 193 | 0.050 |
Why?
|
Agranulocytosis | 4 | 1995 | 20 | 0.050 |
Why?
|
Lung | 4 | 1987 | 1270 | 0.050 |
Why?
|
Lymphatic Metastasis | 7 | 1989 | 496 | 0.050 |
Why?
|
Remission, Spontaneous | 9 | 1980 | 52 | 0.050 |
Why?
|
Etoposide | 5 | 1989 | 205 | 0.050 |
Why?
|
Esophagitis | 3 | 1998 | 43 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 4 | 1989 | 2666 | 0.050 |
Why?
|
Thoracic Surgery | 1 | 1983 | 45 | 0.050 |
Why?
|
Adolescent | 24 | 1990 | 9289 | 0.050 |
Why?
|
Cell Differentiation | 5 | 1992 | 1529 | 0.050 |
Why?
|
Y Chromosome | 2 | 1980 | 29 | 0.050 |
Why?
|
Ventilation-Perfusion Ratio | 2 | 1982 | 13 | 0.050 |
Why?
|
Drug Tolerance | 3 | 1996 | 64 | 0.050 |
Why?
|
DNA | 6 | 1990 | 1309 | 0.050 |
Why?
|
Pedigree | 5 | 2000 | 970 | 0.050 |
Why?
|
Immunotherapy | 1 | 1986 | 686 | 0.050 |
Why?
|
Immunologic Capping | 1 | 1980 | 14 | 0.050 |
Why?
|
Drug Resistance | 3 | 1988 | 232 | 0.040 |
Why?
|
Random Allocation | 4 | 1988 | 327 | 0.040 |
Why?
|
Age Factors | 6 | 1995 | 1876 | 0.040 |
Why?
|
Zymosan | 4 | 1982 | 6 | 0.040 |
Why?
|
Liver | 7 | 1984 | 1208 | 0.040 |
Why?
|
Prospective Studies | 7 | 1995 | 4305 | 0.040 |
Why?
|
Cell Transformation, Neoplastic | 2 | 1982 | 449 | 0.040 |
Why?
|
Multivariate Analysis | 2 | 1995 | 984 | 0.040 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2000 | 112 | 0.040 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 2000 | 79 | 0.040 |
Why?
|
Radiotherapy Dosage | 6 | 1998 | 469 | 0.040 |
Why?
|
Leukemia, Erythroblastic, Acute | 2 | 1978 | 30 | 0.040 |
Why?
|
Bone Marrow Examination | 5 | 1990 | 47 | 0.040 |
Why?
|
Colony-Stimulating Factors | 1 | 1979 | 14 | 0.040 |
Why?
|
Vindesine | 4 | 1989 | 9 | 0.040 |
Why?
|
Rosette Formation | 4 | 1981 | 34 | 0.040 |
Why?
|
Feasibility Studies | 3 | 1997 | 780 | 0.040 |
Why?
|
Cell Nucleus | 5 | 1987 | 601 | 0.040 |
Why?
|
Pilot Projects | 2 | 1994 | 870 | 0.040 |
Why?
|
Ribosomes | 1 | 1980 | 116 | 0.040 |
Why?
|
Hematopoietic System | 1 | 1979 | 13 | 0.040 |
Why?
|
Mediastinum | 3 | 1989 | 47 | 0.040 |
Why?
|
United States | 4 | 2015 | 7033 | 0.040 |
Why?
|
Sex Factors | 6 | 1990 | 1072 | 0.040 |
Why?
|
Radiation Injuries | 4 | 1996 | 162 | 0.040 |
Why?
|
Smoking | 4 | 1990 | 624 | 0.040 |
Why?
|
Risk | 3 | 1998 | 655 | 0.040 |
Why?
|
Radiotherapy, High-Energy | 5 | 1989 | 49 | 0.040 |
Why?
|
Fatty Acids | 1 | 1979 | 134 | 0.040 |
Why?
|
Chromosome Banding | 5 | 1983 | 73 | 0.040 |
Why?
|
Lung Diseases | 2 | 1980 | 272 | 0.040 |
Why?
|
Immunologic Deficiency Syndromes | 2 | 1993 | 47 | 0.040 |
Why?
|
Hematopoiesis | 1 | 1979 | 168 | 0.040 |
Why?
|
Nitrosourea Compounds | 1 | 1978 | 9 | 0.040 |
Why?
|
Splenic Neoplasms | 2 | 1975 | 17 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 1994 | 834 | 0.040 |
Why?
|
Tuberculosis, Pulmonary | 1 | 1978 | 58 | 0.040 |
Why?
|
DNA, Viral | 2 | 1989 | 262 | 0.040 |
Why?
|
Killer Cells, Natural | 2 | 1992 | 276 | 0.040 |
Why?
|
Anemia, Megaloblastic | 1 | 1977 | 1 | 0.040 |
Why?
|
Anemia, Macrocytic | 1 | 1977 | 5 | 0.040 |
Why?
|
Genetic Linkage | 3 | 2000 | 624 | 0.040 |
Why?
|
Hematocrit | 3 | 1983 | 68 | 0.040 |
Why?
|
Pregnancy Complications, Hematologic | 1 | 1977 | 15 | 0.040 |
Why?
|
Triazines | 1 | 1978 | 54 | 0.040 |
Why?
|
Radiography | 3 | 1990 | 806 | 0.040 |
Why?
|
Tumor Cells, Cultured | 3 | 1988 | 1048 | 0.040 |
Why?
|
Thorax | 1 | 1997 | 77 | 0.040 |
Why?
|
Organ Size | 3 | 1983 | 370 | 0.040 |
Why?
|
Disease-Free Survival | 2 | 2000 | 1172 | 0.030 |
Why?
|
Chromosome Mapping | 3 | 1996 | 1074 | 0.030 |
Why?
|
Clinical Trials, Phase II as Topic | 2 | 1995 | 165 | 0.030 |
Why?
|
Bone Marrow Diseases | 3 | 1990 | 40 | 0.030 |
Why?
|
Radiation Dosage | 1 | 1997 | 226 | 0.030 |
Why?
|
Metaphase | 4 | 1980 | 24 | 0.030 |
Why?
|
Sarcoma, Synovial | 2 | 1978 | 21 | 0.030 |
Why?
|
Genes, Dominant | 1 | 1996 | 117 | 0.030 |
Why?
|
Histiocytes | 2 | 1978 | 22 | 0.030 |
Why?
|
Phorbol Esters | 3 | 1984 | 22 | 0.030 |
Why?
|
Mediastinal Neoplasms | 2 | 1989 | 46 | 0.030 |
Why?
|
Fetal Blood | 1 | 1976 | 93 | 0.030 |
Why?
|
Chromosomes, Human, 4-5 | 3 | 1986 | 10 | 0.030 |
Why?
|
Diagnosis, Differential | 4 | 1988 | 1605 | 0.030 |
Why?
|
Fatal Outcome | 1 | 1996 | 296 | 0.030 |
Why?
|
Phosphatidylcholines | 3 | 1984 | 49 | 0.030 |
Why?
|
Dermatitis, Exfoliative | 1 | 1975 | 3 | 0.030 |
Why?
|
Esophageal Neoplasms | 1 | 1998 | 333 | 0.030 |
Why?
|
Patient Care Planning | 1 | 1995 | 83 | 0.030 |
Why?
|
Receptors, Interferon | 2 | 1992 | 33 | 0.030 |
Why?
|
Antibodies, Monoclonal | 4 | 1992 | 1394 | 0.030 |
Why?
|
Androgens | 2 | 1987 | 175 | 0.030 |
Why?
|
Fluorescence | 2 | 1974 | 103 | 0.030 |
Why?
|
Disease Progression | 2 | 1998 | 1462 | 0.030 |
Why?
|
Estrogens | 1 | 1975 | 200 | 0.030 |
Why?
|
Eosinophils | 3 | 1984 | 194 | 0.030 |
Why?
|
Physician Assistants | 1 | 1974 | 21 | 0.030 |
Why?
|
Family | 1 | 1996 | 325 | 0.030 |
Why?
|
Carotid Artery Diseases | 1 | 1975 | 99 | 0.030 |
Why?
|
Receptors, Cell Surface | 1 | 1975 | 288 | 0.030 |
Why?
|
Research Design | 1 | 1997 | 586 | 0.030 |
Why?
|
Pregnancy Complications | 1 | 1976 | 345 | 0.030 |
Why?
|
Nontuberculous Mycobacteria | 2 | 1986 | 10 | 0.030 |
Why?
|
Immunoglobulin kappa-Chains | 2 | 1985 | 96 | 0.030 |
Why?
|
Mitoxantrone | 2 | 1991 | 67 | 0.030 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 1994 | 152 | 0.030 |
Why?
|
Phenotype | 3 | 1989 | 2447 | 0.030 |
Why?
|
Administration, Oral | 2 | 1990 | 666 | 0.030 |
Why?
|
Infusions, Intravenous | 3 | 2001 | 416 | 0.030 |
Why?
|
Skin Neoplasms | 4 | 1985 | 588 | 0.030 |
Why?
|
Digestive System | 2 | 1984 | 42 | 0.030 |
Why?
|
Immunity | 2 | 1992 | 141 | 0.030 |
Why?
|
2-Chloroadenosine | 1 | 1992 | 5 | 0.030 |
Why?
|
Growth Substances | 1 | 1992 | 79 | 0.020 |
Why?
|
Deoxyadenosines | 1 | 1992 | 23 | 0.020 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 4 | 1989 | 269 | 0.020 |
Why?
|
Oncogenes | 1 | 1992 | 97 | 0.020 |
Why?
|
Kidney | 3 | 1984 | 1147 | 0.020 |
Why?
|
Evaluation Studies as Topic | 4 | 1979 | 270 | 0.020 |
Why?
|
Molecular Weight | 4 | 1987 | 331 | 0.020 |
Why?
|
Patient Selection | 1 | 1995 | 676 | 0.020 |
Why?
|
CD11 Antigens | 1 | 1991 | 15 | 0.020 |
Why?
|
CD5 Antigens | 1 | 1991 | 14 | 0.020 |
Why?
|
Antigens, CD20 | 1 | 1991 | 35 | 0.020 |
Why?
|
Logistic Models | 1 | 1995 | 1214 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2000 | 2354 | 0.020 |
Why?
|
Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 1 | 1990 | 17 | 0.020 |
Why?
|
Uterine Neoplasms | 1 | 1975 | 248 | 0.020 |
Why?
|
Lymphocytosis | 1 | 1990 | 12 | 0.020 |
Why?
|
Child | 8 | 1989 | 7210 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 1992 | 477 | 0.020 |
Why?
|
Pelvic Neoplasms | 1 | 1990 | 44 | 0.020 |
Why?
|
Receptors, Immunologic | 3 | 1987 | 136 | 0.020 |
Why?
|
Technetium | 2 | 1983 | 29 | 0.020 |
Why?
|
Flow Cytometry | 2 | 1992 | 689 | 0.020 |
Why?
|
Blood Cells | 2 | 1982 | 33 | 0.020 |
Why?
|
Blood Platelets | 2 | 1981 | 150 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 1990 | 358 | 0.020 |
Why?
|
Emergency Service, Hospital | 1 | 1974 | 523 | 0.020 |
Why?
|
Quinacrine | 4 | 1978 | 14 | 0.020 |
Why?
|
Radiography, Abdominal | 1 | 1989 | 69 | 0.020 |
Why?
|
Colchicine | 3 | 1974 | 24 | 0.020 |
Why?
|
Chicago | 1 | 1994 | 1430 | 0.020 |
Why?
|
Thiotepa | 1 | 1989 | 32 | 0.020 |
Why?
|
Blood Transfusion | 2 | 1989 | 170 | 0.020 |
Why?
|
Central Nervous System | 1 | 1990 | 153 | 0.020 |
Why?
|
Human T-lymphotropic virus 2 | 1 | 1988 | 1 | 0.020 |
Why?
|
Cell Adhesion | 3 | 1985 | 426 | 0.020 |
Why?
|
Gene Amplification | 1 | 1989 | 135 | 0.020 |
Why?
|
Actuarial Analysis | 5 | 1987 | 66 | 0.020 |
Why?
|
Pseudomonas aeruginosa | 2 | 1982 | 202 | 0.020 |
Why?
|
Immunoblotting | 1 | 1989 | 272 | 0.020 |
Why?
|
HLA-B Antigens | 1 | 1988 | 27 | 0.020 |
Why?
|
Melphalan | 1 | 1989 | 98 | 0.020 |
Why?
|
HLA-DR Antigens | 1 | 1988 | 59 | 0.020 |
Why?
|
HLA-C Antigens | 1 | 1988 | 17 | 0.020 |
Why?
|
HLA-A Antigens | 1 | 1988 | 40 | 0.020 |
Why?
|
False Positive Reactions | 2 | 1986 | 223 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 1990 | 394 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 1988 | 164 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 1989 | 204 | 0.020 |
Why?
|
Infant, Newborn | 3 | 1981 | 2487 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 1990 | 846 | 0.020 |
Why?
|
Heat-Shock Proteins | 1 | 1989 | 183 | 0.020 |
Why?
|
Mediastinoscopy | 1 | 1987 | 5 | 0.020 |
Why?
|
Medical Records | 1 | 1988 | 120 | 0.020 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 1989 | 158 | 0.020 |
Why?
|
Vena Cava, Superior | 2 | 1985 | 60 | 0.020 |
Why?
|
Radiotherapy | 3 | 1988 | 332 | 0.020 |
Why?
|
Gene Expression | 1 | 1992 | 1309 | 0.020 |
Why?
|
Radiography, Thoracic | 1 | 1989 | 324 | 0.020 |
Why?
|
Staphylococcus aureus | 2 | 1982 | 276 | 0.020 |
Why?
|
Child, Preschool | 4 | 1989 | 3753 | 0.020 |
Why?
|
Filgrastim | 2 | 1998 | 57 | 0.020 |
Why?
|
Amphotericin B | 1 | 1986 | 34 | 0.020 |
Why?
|
Preoperative Care | 1 | 1989 | 395 | 0.020 |
Why?
|
Follicle Stimulating Hormone | 1 | 1987 | 147 | 0.020 |
Why?
|
Luteinizing Hormone | 1 | 1987 | 167 | 0.020 |
Why?
|
Maxillary Sinus | 1 | 1986 | 26 | 0.020 |
Why?
|
Debridement | 1 | 1986 | 59 | 0.020 |
Why?
|
Platelet Transfusion | 1 | 1986 | 16 | 0.020 |
Why?
|
Physicians | 1 | 1974 | 691 | 0.020 |
Why?
|
BCG Vaccine | 1 | 1986 | 35 | 0.020 |
Why?
|
Breast Neoplasms | 2 | 1983 | 3018 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 1990 | 699 | 0.020 |
Why?
|
Computers | 2 | 1978 | 111 | 0.020 |
Why?
|
Autopsy | 2 | 1984 | 122 | 0.020 |
Why?
|
Antitubercular Agents | 1 | 1986 | 53 | 0.020 |
Why?
|
Immunoglobulin lambda-Chains | 1 | 1985 | 42 | 0.020 |
Why?
|
Sphingomyelins | 2 | 1984 | 16 | 0.020 |
Why?
|
Chromosome Inversion | 2 | 1983 | 47 | 0.020 |
Why?
|
Colony-Forming Units Assay | 2 | 1990 | 40 | 0.020 |
Why?
|
Erythrocyte Transfusion | 1 | 1986 | 72 | 0.020 |
Why?
|
Postoperative Care | 1 | 1986 | 232 | 0.020 |
Why?
|
Testosterone | 1 | 1987 | 272 | 0.020 |
Why?
|
Pregnancy | 3 | 1977 | 3035 | 0.020 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1989 | 394 | 0.020 |
Why?
|
Glycoproteins | 2 | 1984 | 234 | 0.020 |
Why?
|
Busulfan | 1 | 1984 | 41 | 0.020 |
Why?
|
Sepsis | 2 | 1979 | 322 | 0.020 |
Why?
|
Injections, Intravenous | 2 | 1995 | 238 | 0.010 |
Why?
|
Aneuploidy | 3 | 1981 | 57 | 0.010 |
Why?
|
Vascular Diseases | 1 | 1985 | 118 | 0.010 |
Why?
|
Callosities | 1 | 1964 | 1 | 0.010 |
Why?
|
Viola | 1 | 1964 | 1 | 0.010 |
Why?
|
Carrier Proteins | 2 | 1984 | 678 | 0.010 |
Why?
|
Hand Dermatoses | 1 | 1964 | 9 | 0.010 |
Why?
|
Microscopy, Fluorescence | 3 | 1974 | 432 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 1986 | 388 | 0.010 |
Why?
|
Testosterone Congeners | 1 | 1984 | 2 | 0.010 |
Why?
|
Microscopy | 1 | 1984 | 87 | 0.010 |
Why?
|
Histocytochemistry | 2 | 1984 | 130 | 0.010 |
Why?
|
Pleural Neoplasms | 1 | 1986 | 197 | 0.010 |
Why?
|
Anthraquinones | 1 | 1983 | 8 | 0.010 |
Why?
|
Intercalating Agents | 1 | 1983 | 12 | 0.010 |
Why?
|
Respiratory System | 1 | 1984 | 116 | 0.010 |
Why?
|
Plasmapheresis | 1 | 1984 | 25 | 0.010 |
Why?
|
Lithium | 1 | 1984 | 59 | 0.010 |
Why?
|
Cell Survival | 1 | 1986 | 982 | 0.010 |
Why?
|
Deoxyribonucleases | 2 | 1974 | 29 | 0.010 |
Why?
|
Retroviridae Infections | 1 | 1984 | 48 | 0.010 |
Why?
|
Serum Albumin | 1 | 1984 | 127 | 0.010 |
Why?
|
Fingers | 1 | 1964 | 69 | 0.010 |
Why?
|
Head and Neck Neoplasms | 1 | 1991 | 1060 | 0.010 |
Why?
|
Transplantation, Autologous | 1 | 1984 | 345 | 0.010 |
Why?
|
Rib Fractures | 1 | 1983 | 8 | 0.010 |
Why?
|
Megakaryocytes | 1 | 1983 | 36 | 0.010 |
Why?
|
Ribs | 1 | 1983 | 46 | 0.010 |
Why?
|
Lovastatin | 1 | 1983 | 29 | 0.010 |
Why?
|
Disseminated Intravascular Coagulation | 2 | 1980 | 26 | 0.010 |
Why?
|
In Vitro Techniques | 2 | 1987 | 996 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 1990 | 888 | 0.010 |
Why?
|
Carcinoid Tumor | 1 | 1983 | 45 | 0.010 |
Why?
|
Mutagens | 1 | 1982 | 31 | 0.010 |
Why?
|
Insecticides | 1 | 1982 | 27 | 0.010 |
Why?
|
Podophyllotoxin | 1 | 1982 | 10 | 0.010 |
Why?
|
Carcinoma, Renal Cell | 1 | 1986 | 333 | 0.010 |
Why?
|
Hepatitis, Viral, Human | 1 | 1982 | 22 | 0.010 |
Why?
|
Latex | 1 | 1982 | 3 | 0.010 |
Why?
|
Solvents | 1 | 1982 | 96 | 0.010 |
Why?
|
Kinetics | 1 | 1984 | 1534 | 0.010 |
Why?
|
Metals | 1 | 1982 | 93 | 0.010 |
Why?
|
Environmental Exposure | 1 | 1984 | 330 | 0.010 |
Why?
|
Syndrome | 3 | 1981 | 449 | 0.010 |
Why?
|
Immunity, Cellular | 2 | 1979 | 178 | 0.010 |
Why?
|
Culture Techniques | 2 | 1971 | 91 | 0.010 |
Why?
|
Azacitidine | 1 | 1982 | 147 | 0.010 |
Why?
|
Cellulitis | 1 | 1981 | 19 | 0.010 |
Why?
|
Hepatitis | 1 | 1981 | 34 | 0.010 |
Why?
|
Immunologic Techniques | 1 | 1981 | 26 | 0.010 |
Why?
|
Topoisomerase I Inhibitors | 1 | 2001 | 34 | 0.010 |
Why?
|
Liver Neoplasms | 3 | 1979 | 753 | 0.010 |
Why?
|
Infant | 3 | 1989 | 3173 | 0.010 |
Why?
|
Allopurinol | 1 | 1981 | 77 | 0.010 |
Why?
|
Retroperitoneal Neoplasms | 1 | 1981 | 44 | 0.010 |
Why?
|
Myeloproliferative Disorders | 1 | 1983 | 133 | 0.010 |
Why?
|
Central Nervous System Diseases | 2 | 1978 | 52 | 0.010 |
Why?
|
Kidney Neoplasms | 1 | 1986 | 523 | 0.010 |
Why?
|
Abscess | 1 | 1981 | 94 | 0.010 |
Why?
|
Mechlorethamine | 1 | 1980 | 11 | 0.010 |
Why?
|
Immunoglobulin gamma-Chains | 1 | 1980 | 14 | 0.010 |
Why?
|
Chromosomes, Human, Pair 16 | 1 | 2000 | 79 | 0.010 |
Why?
|
Forced Expiratory Volume | 1 | 1980 | 125 | 0.010 |
Why?
|
Loss of Heterozygosity | 1 | 2000 | 86 | 0.010 |
Why?
|
Periodic Acid-Schiff Reaction | 1 | 1980 | 6 | 0.010 |
Why?
|
Tartrates | 1 | 1980 | 6 | 0.010 |
Why?
|
Anemia, Aplastic | 1 | 1980 | 32 | 0.010 |
Why?
|
Lectins | 1 | 1980 | 84 | 0.010 |
Why?
|
Cytogenetics | 1 | 1980 | 27 | 0.010 |
Why?
|
Carboxylic Ester Hydrolases | 1 | 1980 | 24 | 0.010 |
Why?
|
Drug Combinations | 1 | 1980 | 203 | 0.010 |
Why?
|
Hepatitis C | 1 | 1982 | 174 | 0.010 |
Why?
|
Linoleic Acids | 1 | 1979 | 3 | 0.010 |
Why?
|
Blotting, Southern | 2 | 1990 | 127 | 0.010 |
Why?
|
Immunoglobulin D | 2 | 1977 | 5 | 0.010 |
Why?
|
Spinal Cord Neoplasms | 1 | 1980 | 48 | 0.010 |
Why?
|
Postoperative Period | 1 | 1980 | 301 | 0.010 |
Why?
|
Butyrates | 1 | 1980 | 46 | 0.010 |
Why?
|
Cats | 1 | 1980 | 305 | 0.010 |
Why?
|
Rubber | 1 | 1979 | 6 | 0.010 |
Why?
|
Chickens | 1 | 1980 | 212 | 0.010 |
Why?
|
Culture Media | 1 | 1979 | 147 | 0.010 |
Why?
|
Pneumonia | 1 | 1981 | 183 | 0.010 |
Why?
|
Arachidonic Acids | 1 | 1979 | 41 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2000 | 352 | 0.010 |
Why?
|
Blood Platelet Disorders | 1 | 1979 | 12 | 0.010 |
Why?
|
Cattle | 1 | 1980 | 378 | 0.010 |
Why?
|
Terminology as Topic | 2 | 1981 | 221 | 0.010 |
Why?
|
Chromosomes, Human, 1-3 | 1 | 1978 | 1 | 0.010 |
Why?
|
Gastrointestinal Neoplasms | 1 | 1980 | 112 | 0.010 |
Why?
|
Palliative Care | 2 | 1996 | 264 | 0.010 |
Why?
|
Preleukemia | 1 | 1978 | 11 | 0.010 |
Why?
|
Structure-Activity Relationship | 1 | 1979 | 413 | 0.010 |
Why?
|
Pseudomonas Infections | 1 | 1979 | 99 | 0.010 |
Why?
|
Animals | 4 | 1988 | 27453 | 0.010 |
Why?
|
Endoplasmic Reticulum | 1 | 1980 | 255 | 0.010 |
Why?
|
Dactinomycin | 2 | 1989 | 36 | 0.010 |
Why?
|
Ureter | 1 | 1979 | 94 | 0.010 |
Why?
|
Folic Acid Deficiency | 1 | 1977 | 7 | 0.010 |
Why?
|
Colonic Neoplasms | 2 | 1979 | 571 | 0.010 |
Why?
|
Methods | 3 | 1973 | 151 | 0.010 |
Why?
|
Ions | 1 | 1978 | 75 | 0.010 |
Why?
|
Vitamin B 12 | 1 | 1977 | 24 | 0.010 |
Why?
|
Steroids | 1 | 1978 | 173 | 0.010 |
Why?
|
Erythrocytes | 2 | 1977 | 254 | 0.010 |
Why?
|
Hydrocortisone | 1 | 1979 | 301 | 0.010 |
Why?
|
Folic Acid | 1 | 1977 | 63 | 0.010 |
Why?
|
Obstetric Labor Complications | 1 | 1977 | 34 | 0.010 |
Why?
|
Respiration, Artificial | 1 | 1980 | 351 | 0.010 |
Why?
|
Eosinophilia | 1 | 1977 | 84 | 0.010 |
Why?
|
Chromosomes, Human, 19-20 | 1 | 1977 | 5 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 1978 | 194 | 0.010 |
Why?
|
Anemia, Sideroblastic | 1 | 1977 | 7 | 0.010 |
Why?
|
Infant, Newborn, Diseases | 1 | 1977 | 111 | 0.010 |
Why?
|
Testicular Neoplasms | 1 | 1978 | 113 | 0.010 |
Why?
|
Quinacrine Mustard | 1 | 1976 | 2 | 0.010 |
Why?
|
Adenocarcinoma, Bronchiolo-Alveolar | 1 | 1976 | 20 | 0.010 |
Why?
|
Brain | 2 | 1984 | 2292 | 0.010 |
Why?
|
Hemothorax | 1 | 1976 | 15 | 0.010 |
Why?
|
Illinois | 1 | 1978 | 484 | 0.010 |
Why?
|
Sarcoma | 1 | 1978 | 219 | 0.010 |
Why?
|
Mesna | 1 | 1996 | 9 | 0.010 |
Why?
|
Expectorants | 1 | 1996 | 6 | 0.010 |
Why?
|
Cystadenoma | 1 | 1976 | 19 | 0.010 |
Why?
|
Immune Adherence Reaction | 1 | 1976 | 4 | 0.010 |
Why?
|
Base Sequence | 2 | 1988 | 2329 | 0.010 |
Why?
|
Bronchial Neoplasms | 1 | 1976 | 9 | 0.010 |
Why?
|
Inclusion Bodies | 1 | 1976 | 34 | 0.010 |
Why?
|
Mycosis Fungoides | 1 | 1976 | 29 | 0.010 |
Why?
|
Membrane Proteins | 1 | 1982 | 1226 | 0.010 |
Why?
|
Physical Examination | 1 | 1976 | 149 | 0.010 |
Why?
|
Castration | 1 | 1975 | 37 | 0.010 |
Why?
|
Histological Techniques | 2 | 1986 | 36 | 0.010 |
Why?
|
Neoplastic Cells, Circulating | 1 | 1976 | 70 | 0.010 |
Why?
|
Adrenalectomy | 1 | 1975 | 45 | 0.010 |
Why?
|
Genital Neoplasms, Female | 1 | 1976 | 108 | 0.010 |
Why?
|
Keratoderma, Palmoplantar | 1 | 1975 | 3 | 0.010 |
Why?
|
Golgi Apparatus | 1 | 1976 | 116 | 0.010 |
Why?
|
Hypoglossal Nerve | 1 | 1975 | 27 | 0.010 |
Why?
|
Mitogens | 1 | 1975 | 62 | 0.010 |
Why?
|
Microscopy, Ultraviolet | 1 | 1974 | 1 | 0.010 |
Why?
|
Electrophoresis, Starch Gel | 1 | 1974 | 2 | 0.010 |
Why?
|
Maximum Tolerated Dose | 1 | 1995 | 263 | 0.010 |
Why?
|
Canada | 1 | 1995 | 208 | 0.010 |
Why?
|
Neck Dissection | 1 | 1975 | 67 | 0.010 |
Why?
|
Analog-Digital Conversion | 1 | 1974 | 9 | 0.010 |
Why?
|
Genetic Markers | 2 | 1989 | 476 | 0.010 |
Why?
|
Karyometry | 1 | 1974 | 1 | 0.010 |
Why?
|
Chromatids | 1 | 1974 | 7 | 0.010 |
Why?
|
Cervical Vertebrae | 1 | 1975 | 84 | 0.010 |
Why?
|
ABO Blood-Group System | 1 | 1974 | 58 | 0.010 |
Why?
|
Mice | 1 | 1988 | 11812 | 0.010 |
Why?
|
Cell Count | 1 | 1974 | 199 | 0.010 |
Why?
|
Maryland | 1 | 1974 | 43 | 0.010 |
Why?
|
Rural Health | 1 | 1974 | 21 | 0.010 |
Why?
|
Hospitals, Community | 1 | 1974 | 32 | 0.010 |
Why?
|
Photometry | 1 | 1974 | 14 | 0.010 |
Why?
|
Myofibrils | 1 | 1974 | 23 | 0.010 |
Why?
|
False Negative Reactions | 2 | 1987 | 63 | 0.010 |
Why?
|
Health Facilities | 1 | 1974 | 37 | 0.010 |
Why?
|
Acetates | 2 | 1984 | 65 | 0.010 |
Why?
|
Ovary | 1 | 1975 | 262 | 0.010 |
Why?
|
Neuromuscular Diseases | 1 | 1974 | 31 | 0.010 |
Why?
|
Specialization | 1 | 1974 | 70 | 0.010 |
Why?
|
Emergencies | 1 | 1974 | 122 | 0.010 |
Why?
|
Rats | 1 | 1980 | 4040 | 0.010 |
Why?
|
Medicine | 1 | 1974 | 91 | 0.010 |
Why?
|
Affinity Labels | 1 | 1992 | 10 | 0.010 |
Why?
|
Down Syndrome | 1 | 1973 | 55 | 0.010 |
Why?
|
Blotting, Northern | 1 | 1992 | 258 | 0.010 |
Why?
|
Cross-Linking Reagents | 1 | 1992 | 88 | 0.010 |
Why?
|
Mitochondria | 1 | 1976 | 553 | 0.010 |
Why?
|
Densitometry | 1 | 1971 | 29 | 0.010 |
Why?
|
Spectrophotometry | 1 | 1971 | 108 | 0.010 |
Why?
|
Haploidy | 1 | 1971 | 32 | 0.010 |
Why?
|
Spermatozoa | 1 | 1971 | 62 | 0.010 |
Why?
|
Quality of Health Care | 1 | 1974 | 386 | 0.010 |
Why?
|
Tritium | 2 | 1984 | 133 | 0.010 |
Why?
|
Cryopreservation | 1 | 1990 | 70 | 0.010 |
Why?
|
Incidence | 1 | 1994 | 1598 | 0.010 |
Why?
|
Ovarian Neoplasms | 1 | 1976 | 766 | 0.010 |
Why?
|
Genotype | 1 | 1974 | 1852 | 0.010 |
Why?
|
Human T-lymphotropic virus 1 | 1 | 1989 | 14 | 0.010 |
Why?
|
DNA Probes | 1 | 1989 | 77 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 1974 | 435 | 0.010 |
Why?
|
Histones | 1 | 1971 | 332 | 0.010 |
Why?
|
Nucleic Acid Hybridization | 1 | 1989 | 243 | 0.010 |
Why?
|
Herpesvirus 4, Human | 1 | 1989 | 120 | 0.000 |
Why?
|
Heart | 1 | 1991 | 574 | 0.000 |
Why?
|
Isoelectric Point | 1 | 1987 | 16 | 0.000 |
Why?
|
Cytosol | 1 | 1987 | 193 | 0.000 |
Why?
|
Peritoneum | 1 | 1986 | 57 | 0.000 |
Why?
|
RNA, Messenger | 1 | 1992 | 2021 | 0.000 |
Why?
|
Cost-Benefit Analysis | 1 | 1989 | 464 | 0.000 |
Why?
|
Leukemia, Radiation-Induced | 1 | 1986 | 14 | 0.000 |
Why?
|
Lymph Node Excision | 1 | 1987 | 219 | 0.000 |
Why?
|
Catheterization | 1 | 1986 | 237 | 0.000 |
Why?
|
Occupations | 1 | 1985 | 25 | 0.000 |
Why?
|
Lymphopenia | 1 | 1985 | 30 | 0.000 |
Why?
|
Phorbol 12,13-Dibutyrate | 1 | 1984 | 20 | 0.000 |
Why?
|
Antimetabolites | 1 | 1985 | 24 | 0.000 |
Why?
|
Carbon Radioisotopes | 1 | 1984 | 35 | 0.000 |
Why?
|
Acetic Acid | 1 | 1984 | 8 | 0.000 |
Why?
|
Probability | 1 | 1986 | 350 | 0.000 |
Why?
|
Choline | 1 | 1984 | 24 | 0.000 |
Why?
|
RNA | 1 | 1989 | 581 | 0.000 |
Why?
|
Oligosaccharides | 1 | 1984 | 24 | 0.000 |
Why?
|
Migraine Disorders | 1 | 1985 | 40 | 0.000 |
Why?
|
Cell Line | 1 | 1989 | 2494 | 0.000 |
Why?
|
Genetic Variation | 1 | 1971 | 1380 | 0.000 |
Why?
|
Carcinogens | 1 | 1984 | 111 | 0.000 |
Why?
|
Caffeine | 1 | 1985 | 83 | 0.000 |
Why?
|
Anemia | 1 | 1985 | 129 | 0.000 |
Why?
|
Hematologic Diseases | 1 | 1984 | 78 | 0.000 |
Why?
|
Mevalonic Acid | 1 | 1983 | 13 | 0.000 |
Why?
|
Hydroxycholesterols | 1 | 1983 | 6 | 0.000 |
Why?
|
Concanavalin A | 1 | 1983 | 52 | 0.000 |
Why?
|
Dogs | 1 | 1984 | 704 | 0.000 |
Why?
|
Naphthalenes | 1 | 1983 | 42 | 0.000 |
Why?
|
Alcohol Drinking | 1 | 1985 | 274 | 0.000 |
Why?
|
Liver Function Tests | 1 | 1982 | 92 | 0.000 |
Why?
|
Cyclic AMP | 1 | 1983 | 275 | 0.000 |
Why?
|
Primary Myelofibrosis | 1 | 1982 | 67 | 0.000 |
Why?
|
Nervous System Neoplasms | 1 | 1981 | 11 | 0.000 |
Why?
|
Histocompatibility Testing | 1 | 1981 | 137 | 0.000 |
Why?
|
Chromosomes, Human | 1 | 1981 | 65 | 0.000 |
Why?
|
Aorta, Thoracic | 1 | 1982 | 168 | 0.000 |
Why?
|
Nausea | 1 | 1982 | 175 | 0.000 |
Why?
|
Tennessee | 1 | 1980 | 16 | 0.000 |
Why?
|
Registries | 1 | 1985 | 790 | 0.000 |
Why?
|
Dexamethasone | 1 | 1982 | 342 | 0.000 |
Why?
|
Pulmonary Artery | 1 | 1982 | 320 | 0.000 |
Why?
|
Citrates | 1 | 1979 | 28 | 0.000 |
Why?
|
Skin Tests | 1 | 1979 | 44 | 0.000 |
Why?
|
Dinitrochlorobenzene | 1 | 1979 | 3 | 0.000 |
Why?
|
Norepinephrine | 1 | 1979 | 172 | 0.000 |
Why?
|
Adenosine Deaminase | 1 | 1979 | 21 | 0.000 |
Why?
|
Histiocytoma, Benign Fibrous | 1 | 1978 | 25 | 0.000 |
Why?
|
Liposarcoma | 1 | 1978 | 12 | 0.000 |
Why?
|
Soft Tissue Neoplasms | 1 | 1979 | 128 | 0.000 |
Why?
|
Reticulin | 1 | 1978 | 4 | 0.000 |
Why?
|
Rhabdomyosarcoma | 1 | 1978 | 42 | 0.000 |
Why?
|
Erythrocytes, Abnormal | 1 | 1978 | 12 | 0.000 |
Why?
|
Neurilemmoma | 1 | 1978 | 34 | 0.000 |
Why?
|
Sarcoma, Ewing | 1 | 1978 | 44 | 0.000 |
Why?
|
Lymphography | 1 | 1978 | 27 | 0.000 |
Why?
|
Diagnostic Errors | 1 | 1979 | 160 | 0.000 |
Why?
|
Uterine Cervical Neoplasms | 1 | 1981 | 297 | 0.000 |
Why?
|
Fibrosarcoma | 1 | 1978 | 85 | 0.000 |
Why?
|
Leiomyosarcoma | 1 | 1978 | 45 | 0.000 |
Why?
|
Cardiomyopathies | 1 | 1981 | 265 | 0.000 |
Why?
|
Pancreas | 1 | 1979 | 249 | 0.000 |
Why?
|
Genetic Techniques | 1 | 1977 | 73 | 0.000 |
Why?
|
Multiple Myeloma | 1 | 1981 | 331 | 0.000 |
Why?
|
Skin Manifestations | 1 | 1977 | 2 | 0.000 |
Why?
|
Hepatomegaly | 1 | 1977 | 16 | 0.000 |
Why?
|
Glutathione Reductase | 1 | 1977 | 7 | 0.000 |
Why?
|
Phosphogluconate Dehydrogenase | 1 | 1977 | 3 | 0.000 |
Why?
|
Glucosephosphate Dehydrogenase | 1 | 1977 | 18 | 0.000 |
Why?
|
Pyruvate Kinase | 1 | 1977 | 13 | 0.000 |
Why?
|
Anemia, Hemolytic, Autoimmune | 1 | 1977 | 14 | 0.000 |
Why?
|
Agammaglobulinemia | 1 | 1977 | 20 | 0.000 |
Why?
|
Surveys and Questionnaires | 1 | 1985 | 2641 | 0.000 |
Why?
|
Bone Diseases | 1 | 1977 | 57 | 0.000 |
Why?
|
Immunoglobulin M | 1 | 1977 | 163 | 0.000 |
Why?
|
Circadian Rhythm | 1 | 1979 | 304 | 0.000 |
Why?
|
Gastrointestinal Diseases | 1 | 1977 | 150 | 0.000 |
Why?
|
Reflex, Stretch | 1 | 1974 | 5 | 0.000 |
Why?
|
Paresthesia | 1 | 1974 | 15 | 0.000 |
Why?
|
Kidney Diseases | 1 | 1977 | 320 | 0.000 |
Why?
|
Mitochondria, Muscle | 1 | 1974 | 27 | 0.000 |
Why?
|
Genes, Recessive | 1 | 1974 | 87 | 0.000 |
Why?
|
Muscles | 1 | 1974 | 193 | 0.000 |
Why?
|
Mustard Compounds | 1 | 1973 | 1 | 0.000 |
Why?
|
Dermatoglyphics | 1 | 1973 | 4 | 0.000 |
Why?
|
Autoradiography | 1 | 1973 | 69 | 0.000 |
Why?
|
Urea | 1 | 1973 | 59 | 0.000 |
Why?
|
Adenosine Triphosphatases | 1 | 1974 | 154 | 0.000 |
Why?
|
Ear, External | 1 | 1973 | 26 | 0.000 |
Why?
|
Face | 1 | 1973 | 117 | 0.000 |
Why?
|
Genes | 1 | 1973 | 306 | 0.000 |
Why?
|